Assenagon Asset Management’s Calithera Biosciences, Inc CALA Stock Holding History

Assenagon Asset Management’s Portfolio CALA Stock Details CALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-37,684	Closed	-$304K	–	1639
2022 Q1	$304K	Hold	37,684	–	–	﹤0.01%	1292
2021 Q4	$501K	Sell	37,684 -5	-0%	-$126	﹤0.01%	1197
2021 Q3	$1.64M	Buy	37,689 +20,149	+115%	+$869K	0.01%	759
2021 Q2	$733K	Buy	+17,540	New	+$771K	﹤0.01%	964
2020 Q4	–	Sell	-9,995	Closed	-$690K	–	1322
2020 Q3	$690K	Sell	9,995 -4,689	-32%	-$409K	﹤0.01%	926
2020 Q2	$1.55M	Buy	+14,684	New	+$1.74M	0.01%	672
2019 Q4	–	Sell	-521	Closed	-$32K	–	997
2019 Q3	$32K	Sell	521 -7,599	-94%	-$608K	﹤0.01%	804
2019 Q2	$633K	Buy	+8,120	New	+$922K	﹤0.01%	809

Other funds holding CALA

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCMG

TSP Capital Management Group Summit, New Jersey $410M AUM 71.81% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Assenagon Asset Management's CALA Position: Q2 2022 in Review

Assenagon Asset Management sold out of Calithera Biosciences, Inc (CALA) in Q2 2022, closing a stake of 37,684 shares — an estimated $304K sold.

Assenagon Asset Management first reported a position in CALA in Q2 2019 and held it in 8 quarters. The position peaked at $1.64M in Q3 2021. 28 funds tracked by Wall St. Rank hold CALA as of Q2 2022.

Assenagon Asset Management reported no remaining Calithera Biosciences, Inc position as of Q2 2022 after selling out during the quarter.
Assenagon Asset Management sold 37,684 Calithera Biosciences, Inc shares in Q2 2022, an estimated $304K.
Assenagon Asset Management first reported a position in Calithera Biosciences, Inc in Q2 2019 and held it in 8 quarters.
Assenagon Asset Management's Calithera Biosciences, Inc position peaked at $1.64M in Q3 2021.
28 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q2 2022.

Based on Assenagon Asset Management's 13F filing for Q2 2022, filed 27 Jul 2022.